NO20003965L - - Google Patents
Info
- Publication number
- NO20003965L NO20003965L NO20003965A NO20003965A NO20003965L NO 20003965 L NO20003965 L NO 20003965L NO 20003965 A NO20003965 A NO 20003965A NO 20003965 A NO20003965 A NO 20003965A NO 20003965 L NO20003965 L NO 20003965L
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7380198P | 1998-02-05 | 1998-02-05 | |
| PCT/IB1999/000067 WO1999040061A2 (en) | 1998-02-05 | 1999-01-18 | Novel dihydroxyhexanoic acid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20003965D0 NO20003965D0 (no) | 2000-08-04 |
| NO20003965L true NO20003965L (cs) | 2000-10-03 |
Family
ID=22115885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20003965A NO20003965D0 (no) | 1998-02-05 | 2000-08-04 | Nye dihydroksyheksansyre-derivater |
Country Status (36)
| Country | Link |
|---|---|
| EP (1) | EP1051405B1 (cs) |
| JP (1) | JP3693916B2 (cs) |
| KR (1) | KR100385529B1 (cs) |
| CN (1) | CN1177834C (cs) |
| AP (1) | AP992A (cs) |
| AR (1) | AR016175A1 (cs) |
| AT (1) | ATE337307T1 (cs) |
| AU (1) | AU752407B2 (cs) |
| BG (1) | BG104726A (cs) |
| BR (1) | BR9907655A (cs) |
| CA (1) | CA2320388C (cs) |
| DE (1) | DE69932920T2 (cs) |
| DZ (1) | DZ2717A1 (cs) |
| EA (1) | EA003137B1 (cs) |
| ES (1) | ES2268847T3 (cs) |
| GT (1) | GT199900011A (cs) |
| HR (1) | HRP20000529B1 (cs) |
| HU (1) | HUP0100832A3 (cs) |
| IL (1) | IL137330A0 (cs) |
| IS (1) | IS5562A (cs) |
| MA (1) | MA26603A1 (cs) |
| MY (1) | MY133125A (cs) |
| NO (1) | NO20003965D0 (cs) |
| NZ (1) | NZ505724A (cs) |
| OA (1) | OA11448A (cs) |
| PA (1) | PA8467301A1 (cs) |
| PE (1) | PE20000243A1 (cs) |
| PL (1) | PL342817A1 (cs) |
| SK (1) | SK11262000A3 (cs) |
| TN (1) | TNSN99013A1 (cs) |
| TR (1) | TR200002248T2 (cs) |
| TW (1) | TW470744B (cs) |
| UA (1) | UA57824C2 (cs) |
| WO (1) | WO1999040061A2 (cs) |
| YU (1) | YU47100A (cs) |
| ZA (1) | ZA99873B (cs) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2862300A (en) * | 1999-01-29 | 2000-08-18 | Millennium Pharmaceuticals, Inc. | Methods for preventing graft rejection and ischemia-reperfusion injury |
| CZ2002487A3 (cs) * | 1999-08-20 | 2002-06-12 | Dow Agrosciences Llc | Fungicidní heterocyklické aromatické amidy, prostředky na jejich bázi, způsoby jejich pouľití a přípravy |
| EP1498417A1 (en) * | 2000-02-04 | 2005-01-19 | Pfizer Products Inc. | Heterocyclic amide derivatives |
| GEP20043301B (en) | 2000-02-04 | 2004-02-10 | Pfizer Prod Inc | Heterocyclic Amide Derivatives, Pharmaceutical Compositions Containing the Same and Use Thereof for Treatment of Inflammation and Other Immune Disorders |
| US6740636B2 (en) | 2000-07-31 | 2004-05-25 | Schering Aktiengesellschaft | Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection |
| US6746856B2 (en) | 2000-08-09 | 2004-06-08 | Pfizer Inc. | Microbial conversion of bicyclic heteroaromatic compounds |
| EP1269994A3 (en) * | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| KR100768766B1 (ko) | 2001-06-22 | 2007-10-19 | 화이자 프로덕츠 인코포레이티드 | 비정질 약물의 흡착체의 약학 조성물 |
| WO2003000235A1 (en) | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| DE10152351B4 (de) * | 2001-10-18 | 2005-09-22 | Schering Ag | Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat |
| BR0307344A (pt) | 2002-02-01 | 2004-12-14 | Pfizer Prod Inc | Composições farmacêuticas de dispersões amorfas de fármacos e materiais formadores de microfase lipofìlica |
| JP2005527604A (ja) * | 2002-05-14 | 2005-09-15 | ファイザー・プロダクツ・インク | ジヒドロフラン２オン誘導体の製造方法 |
| JP2005530775A (ja) * | 2002-05-14 | 2005-10-13 | ファイザー・プロダクツ・インク | ジヒドロキシヘキサン酸誘導体、それらの中間体、および製法 |
| AU2003250450A1 (en) * | 2002-08-12 | 2004-02-25 | Pfizer Products Inc. | Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide |
| PL375345A1 (en) | 2002-08-12 | 2005-11-28 | Pfizer Products Inc. | Pharmaceutical compositions of semi-ordered drugs and polymers |
| US20040087571A1 (en) * | 2002-10-30 | 2004-05-06 | Pfizer Inc | Methods of using CCR1 antagonists as immunomodulatory agents |
| US20040097554A1 (en) * | 2002-10-30 | 2004-05-20 | Pfizer Inc | Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents |
| ATE540671T1 (de) | 2003-08-04 | 2012-01-15 | Bend Res Inc | Pharmazeutische zusammensetzungen von adsorbaten von amorphen arzneimitteln und lipophilen mikrophasen-bildenden materialien |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923864A (en) * | 1987-12-15 | 1990-05-08 | Pfizer Inc. | Certain heterocyclic-hexanamides useful for treating hypertension |
| DK0708085T3 (da) * | 1994-10-19 | 2002-11-11 | Novartis Ag | Antivirale ethere af aspartatproteasesubstrat-isostere |
| DE19708106A1 (de) * | 1997-02-28 | 1998-09-03 | Bosch Gmbh Robert | Einrichtung und Verfahren zur Information über Verkehrsstörungen |
-
1999
- 1999-01-18 IL IL13733099A patent/IL137330A0/xx unknown
- 1999-01-18 KR KR10-2000-7008561A patent/KR100385529B1/ko not_active Expired - Fee Related
- 1999-01-18 NZ NZ505724A patent/NZ505724A/xx unknown
- 1999-01-18 DE DE69932920T patent/DE69932920T2/de not_active Expired - Lifetime
- 1999-01-18 PA PA19998467301A patent/PA8467301A1/es unknown
- 1999-01-18 CA CA002320388A patent/CA2320388C/en not_active Expired - Fee Related
- 1999-01-18 HR HR20000529 patent/HRP20000529B1/xx not_active IP Right Cessation
- 1999-01-18 CN CNB998027138A patent/CN1177834C/zh not_active Expired - Fee Related
- 1999-01-18 EP EP99900098A patent/EP1051405B1/en not_active Expired - Lifetime
- 1999-01-18 UA UA2000074534A patent/UA57824C2/uk unknown
- 1999-01-18 ES ES99900098T patent/ES2268847T3/es not_active Expired - Lifetime
- 1999-01-18 BR BR9907655-1A patent/BR9907655A/pt not_active Application Discontinuation
- 1999-01-18 JP JP2000530493A patent/JP3693916B2/ja not_active Expired - Lifetime
- 1999-01-18 YU YU47100A patent/YU47100A/sh unknown
- 1999-01-18 PL PL99342817A patent/PL342817A1/xx not_active Application Discontinuation
- 1999-01-18 TR TR2000/02248T patent/TR200002248T2/xx unknown
- 1999-01-18 EA EA200000741A patent/EA003137B1/ru not_active IP Right Cessation
- 1999-01-18 AU AU17789/99A patent/AU752407B2/en not_active Ceased
- 1999-01-18 SK SK1126-2000A patent/SK11262000A3/sk unknown
- 1999-01-18 AT AT99900098T patent/ATE337307T1/de not_active IP Right Cessation
- 1999-01-18 HU HU0100832A patent/HUP0100832A3/hu unknown
- 1999-01-18 WO PCT/IB1999/000067 patent/WO1999040061A2/en not_active Ceased
- 1999-01-27 GT GT199900011A patent/GT199900011A/es unknown
- 1999-02-01 PE PE1999000071A patent/PE20000243A1/es not_active Application Discontinuation
- 1999-02-01 TW TW088101505A patent/TW470744B/zh not_active IP Right Cessation
- 1999-02-03 AR ARP990100443A patent/AR016175A1/es unknown
- 1999-02-03 DZ DZ990018A patent/DZ2717A1/xx active
- 1999-02-03 MA MA25448A patent/MA26603A1/fr unknown
- 1999-02-03 TN TNTNSN99013A patent/TNSN99013A1/fr unknown
- 1999-02-03 MY MYPI99000363A patent/MY133125A/en unknown
- 1999-02-04 AP APAP/P/1999/001457A patent/AP992A/en active
- 1999-02-04 ZA ZA9900873A patent/ZA99873B/xx unknown
-
2000
- 2000-07-14 IS IS5562A patent/IS5562A/is unknown
- 2000-07-28 OA OA1200000214A patent/OA11448A/en unknown
- 2000-08-04 NO NO20003965A patent/NO20003965D0/no not_active Application Discontinuation
- 2000-08-29 BG BG104726A patent/BG104726A/xx unknown
Also Published As
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |